UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Select Medical Corporation
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
816196-10-9
--------------------------------------------------------------------------------
(CUSIP Number)
February 26, 2003
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
/_/ Rule 13d-1(b)
/x/ Rule 13d-1(c)
/_/ Rule 13d-1(d)
---------------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior coverage page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 Pages
CUSIP No. 816196-10-9 13G Page 2 of 5 Pages
--------- ----------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Robert A. Ortenzio
--------- ----------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) /_/
(b) /x/
--------- ----------------------------------------------------------------------
3. SEC USE ONLY
--------- ----------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------ ----- -------------------------------------------------
NUMBER OF
SHARES 5. SOLE VOTING POWER 2,343,265
BENEFICIALLY
OWNED BY ----- -------------------------------------------------
EACH
REPORTING 6. SHARED VOTING POWER 246,857
PERSON WITH
----- -------------------------------------------------
7. SOLE DISPOSITIVE POWER 2,343,265
----- -------------------------------------------------
8. SHARED DISPOSITIVE POWER 246,857
--------- ----------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,590,122
--------- ----------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES /_/
--------- ----------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.3%
--------- ----------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
IN
--------- ----------------------------------------------------------------------
CUSIP No. 816196-10-9 13G Page 3 of 5 Pages
Item 1(a). Name of Issuer:
Select Medical Corporation
Item 1(b). Address of Issuer's Principal Executive Offices:
4716 Old Gettysburg Road
P.O. Box 2034
Mechanicsburg, PA 17055
Item 2(a). Name of Person Filing:
Robert A. Ortenzio
Item 2(b). Address of Principal Business Office or, if None, Residence:
4716 Old Gettysburg Road
P.O. Box 2034
Mechanicsburg, PA 17055
Item 2(c). Citizenship:
United States
Item 2(d). Title of Class of Securities:
Common Stock, par value $.01 per share
Item 2(e) CUSIP Number:
816196-10-9
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a:
(a) /_/ Broker or dealer registered under Section 15 of the
Exchange Act.
(b) /_/ Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) /_/ Insurance company as defined in Section 3(a)(19) of the
Exchange Act.
(d) /_/ Investment company registered under Section 8 of the
Investment Company Act.
(e) /_/ An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E);
(f) /_/ An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F);
(g) /_/ A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G);
(h) /_/ A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act;
CUSIP No. 816196-10-9 13G Page 4 of 5 Pages
(i) /_/ A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) /_/ Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 2,590,122
(b) Percent of class: 5.3%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote
2,343,265
(ii) Shared power to vote or to direct the vote
246,857
(iii) Sole power to dispose or to direct the disposition of
2,343,265
(iv) Shared power to dispose or to direct the disposition of
246,857
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ ].
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
N/A
Item 8. Identification and Classification of Members of the Group.
N/A
Item 9. Notice of Dissolution of Group.
N/A
CUSIP No. 816196-10-9 13G Page 5 of 5 Pages
Item 10. Certifications.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing control of the issuer
of the securities and were not acquired and are not held in connection with or
as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
/s/ Robert A. Ortenzio
---------------------------
Robert A. Ortenzio
Dated: March 7, 2003
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative other than an executive
officer or general partner of the filing person, evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties for whom copies are to be sent.
Attention: International misstatements or omissions of fact constitute Federal
criminal violations. (See 18 U.S.C. 1001)